Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).

Mobility disabilities plague elderly cancer survivors

20 Oct 2020

Elderly survivors of cancer are more likely to need mobility devices than those without such a history, a recent study has found.

Researchers conducted a cross-sectional analysis on a nationally representative sample of 6,080 elderly adults, of whom 1,203 had survived cancer. Through in-person home interviews, information about use of mobility devices (canes, scooters, wheelchairs, and walkers), falls, and pain were collected. Participants also underwent the 3-m gait speed test to estimate mobility disability.

Overall, 20 percent of the participants said they had used a mobility device in the last month. Of these, 7.35 percent used two or more devices. The single-point cane was the most commonly used device, while the scooter was the least.

Elderly adults with a history of cancer tended to use mobility devices more than their noncancer counterparts (23.4 percent vs 19 percent). Ten percent of breast cancer survivors, 5.7 percent of prostate cancer survivors, and 3.4 percent of colorectal cancer survivors reported using two or more devices in the past month.

Logistic regression analysis, however, showed that this difference in mobility device use was not statistically significant (odds ratio [OR], 1.23, 95 percent confidence interval [CI], 0.96–1.57; p=0.10).

In terms of mobility disabilities, cancer survivors showed lower mean gait speed score than controls (2.27 vs 2.39), and the resulting odds estimate was statistically significant (OR, 0.82, 95 percent CI, 0.67–1.00; p<0.05).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).